Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
Completed
Conditions studied: Parkinsonism
In brief
The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments. Outcome variables include selected gait and balance parameters such as cadence, gait-cycle, stride-length, stride-velocity, turning duration, turning steps, postural sway and anticipatory postural control. These parameters will be measured by the portable inertial sensors developed by APDM® and the Zeno/GaitRite.
Key facts
- Study ID
- NCT02064543
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 24
- Starts
- 2013-07-01
- Expected to finish
- 2017-01-01
- Last updated by the study team
- 2019-09-18
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults between the ages of 18 and 80 years of age with a primary diagnosis of PD and similar parkinsonian syndromes
- Individuals able to walk 100 feet independently, with or without the use of an assistive device (walker, cane) and follow simple instructions.
- Individuals with sufficient physiological systemic support to participate in the study protocol
You may not qualify if…
- Inability to speak English secondary to the need to understand and follow multistep directions
- A secondary diagnosis (musculoskeletal, cardiopulmonary, neurological) that excludes participation in the study
- Inability to ambulate 100 feet independently with or without an assistive device.
- Inability to follow simple instructions necessary for completion of the testing tasks.
Where it is running
- UT Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.